SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950134-99-004591
Filing Date
1999-05-19
Accepted
1999-05-19 00:00:00
Documents
1
Period of Report
1999-07-07

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT PRE 14A 86276
  Complete submission text file 0000950134-99-004591.txt   87870
Mailing Address 370 17TH STREET SUITE 5200 DENVER CO 802025638
Business Address 370 17TH STREET SUITE 5200 DENVER CO 80202-5638 3032799375
GOLDEN PHARMACEUTICALS INC (Filer) CIK: 0000312651 (see all company filings)

IRS No.: 840645174 | State of Incorp.: CO | Fiscal Year End: 0831
Type: PRE 14A | Act: 34 | File No.: 000-09065 | Film No.: 99630427
SIC: 2835 In Vitro & In Vivo Diagnostic Substances